By Dr Steven Thomas Leach

Journal articles

Alhagamhmad MH; Day AS; Lemberg DA; Leach ST, 2017, 'Exploring and enhancing the anti-inflammatory properties of polymeric formula', Journal of Parenteral and Enteral Nutrition, 41, pp. 436 - 445, http://dx.doi.org/10.1177/0148607115625627

Lopez RN; Leach ST; Lemberg DA; Duvoisin G; Gearry RB; Day AS, 2017, 'Fecal biomarkers in inflammatory bowel disease', Journal of Gastroenterology and Hepatology (Australia), 32, pp. 577 - 582, http://dx.doi.org/10.1111/jgh.13611

Duvoisin G; Lopez RN; Day AS; Lemberg DA; Gearry RB; Leach ST, 2017, 'Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease', Mediators of Inflammation, 2017, pp. 1936315, http://dx.doi.org/10.1155/2017/1936315

Garg M; Leach ST; Coffey MJ; Katz T; Strachan R; Needham B; Lui K; Ali F; Day AS; Appleton L; Moeeni V; Jaffe A; Ooi CY, 2017, 'Age-Dependent Values of Fecal Calprotectin in Cystic Fibrosis and Healthy Controls', Gastroenterology, 152, pp. S645 - S645, http://dx.doi.org/10.1016/s0016-5085(17)32281-3

Garg M; Leach ST; Needham B; Coffey MJ; Katz T; Strachan R; Widger J; Field P; Belessis Y; Chuang S; Day AS; Jaffe A; Ooi CY, 2017, 'Determining the Age-Related Levels of Fecal M2-Pyruvate Kinase in Children with Cystic Fibrosis During the First Decade of Life', Gastroenterology, 152, pp. S645 - S646, http://dx.doi.org/10.1016/s0016-5085(17)32282-5

Garg M; Leach ST; Coffey MJ; Katz T; Strachan R; Needham B; Lui K; Ali F; Day AS; Appleton L; Moeeni V; Jaffe A; Ooi CY, 2017, 'EPS3.1 Age-dependent values of fecal calprotectin in cystic fibrosis and healthy children', Journal of Cystic Fibrosis, 16, pp. S41 - S41, http://dx.doi.org/10.1016/s1569-1993(17)30292-8

Garg M; Leach ST; Needham B; Coffey MJ; Katz TE; Strachan R; Widger J; Field P; Belessis Y; Chuang S; Day AS; Jaffe A; Ooi CY, 2017, 'WS21.1 Determining the age-related levels of fecal M2-pyruvate kinase in children with cystic fibrosis during the first decade of life', Journal of Cystic Fibrosis, 16, pp. S34 - S34, http://dx.doi.org/10.1016/s1569-1993(17)30268-0

Safe M; Chan WH; Leach ST; Sutton L; Lui K; Krishnan U, 2016, 'Widespread use of gastric acid inhibitors in infants: Are they needed? Are they safe?', World J Gastrointest Pharmacol Ther, 7, pp. 531 - 539, http://dx.doi.org/10.4292/wjgpt.v7.i4.531

Alhagamhmad MH; Day AS; Lemberg DA; Leach ST, 2016, 'An overview of the bacterial contribution to Crohn disease pathogenesis', Journal of Medical Microbiology, 65, pp. 1049 - 1059, http://dx.doi.org/10.1099/jmm.0.000331

Kaakoush NO; Thomas DS; Ruzayqat MM; Lynch D; Leach ST; Lemberg DA; Day AS; Mitchell HM, 2016, 'Campylobacter concisus utilizes blood but not short chain fatty acids despite showing associations with firmicutes taxa', Microbiology (United Kingdom), 162, pp. 1388 - 1397, http://dx.doi.org/10.1099/mic.0.000328

Kaakoush NO; Thomas DS; Ruzayqat MM; Lynch D; Leach ST; Lemberg DA; Day AS; Mitchell HM, 2016, 'Campylobacter concisus utilizes blood but not short chain fatty acids despite showing associations with Firmicutes taxa', MICROBIOLOGY-SGM, 162, pp. 1388 - 1397, http://dx.doi.org/10.1099/mic.0.000328

Kaakoush NO; Day AS; Leach ST; Lemberg DA; Mitchell HM, 2016, 'Reduction in Gut Microbial Diversity as a Mechanism of Action of Exclusive Enteral Nutrition', American Journal of Gastroenterology, 111, pp. 1033, http://dx.doi.org/10.1038/ajg.2016.61

Nielsen S; Needham B; Leach ST; Day AS; Jaffe A; Thomas T; Ooi CY, 2016, 'Disrupted progression of the intestinal microbiota with age in children with cystic fibrosis', Scientific Reports, 6, pp. 24857, http://dx.doi.org/10.1038/srep24857

Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Keenan JI; Leach S; Burgess L; Aitchison A; Gorelik A; Liew D; Day AS; Gearry RB, 2016, 'Comparison of fecal inflammatory markers in Crohn's disease', Inflammatory Bowel Diseases, 22, pp. 1086 - 1094, http://dx.doi.org/10.1097/MIB.0000000000000671

Leach ST; Lui K; Naing Z; Dowd SE; Mitchell HM; Day AS, 2015, 'Multiple Opportunistic Pathogens, but Not Pre-existing Inflammation, May Be Associated with Necrotizing Enterocolitis', Digestive Diseases and Sciences, 60, pp. 3728 - 3734, http://dx.doi.org/10.1007/s10620-015-3830-6

Ooi CY; Pang T; Leach ST; Katz T; Day AS; Jaffe A, 2015, 'Fecal Human β-Defensin 2 in Children with Cystic Fibrosis: Is There a Diminished Intestinal Innate Immune Response?', Digestive Diseases and Sciences, 60, pp. 2946 - 2952, http://dx.doi.org/10.1007/s10620-015-3842-2

Shepherd D; Day AS; Leach ST; Lopez R; Messenger R; Woodhead HJ; Ledder O; Lemberg DA, 2015, 'Single high-dose oral Vitamin D3 therapy (Stoss): A solution to Vitamin D deficiency in children with inflammatory bowel disease?', Journal of Pediatric Gastroenterology and Nutrition, 61, pp. 411 - 414, http://dx.doi.org/10.1097/MPG.0000000000000823

Nahidi L; Corley SM; Wilkins MR; Wei J; Alhagamhmad M; Day AS; Lemberg DA; Leach ST, 2015, 'The major pathway by which polymeric formula reduces inflammation in intestinal epithelial cells: a microarray-based analysis', Genes and Nutrition, 10, http://dx.doi.org/10.1007/s12263-015-0479-x

Pang T; Leach ST; Katz T; Jaffe A; Day AS; Ooi CY, 2015, 'Elevated fecal M2-pyruvate kinase in children with cystic fibrosis: A clue to the increased risk of intestinal malignancy in adulthood?', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 30, pp. 866 - 871, http://dx.doi.org/10.1111/jgh.12842

Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Krejany EO; Leach S; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Jakobovits SL; Florin TH; Gibson PR; Debinski H; Macrae FA; Samuel D; Kronborg I; Radford-Smith G; Selby W; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Day AS; Desmond PV; Gearry RB, 2015, 'Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery', Gastroenterology, 148, pp. 938 - 947.e1, http://dx.doi.org/10.1053/j.gastro.2015.01.026

Kaakoush NO; Day AS; Leach ST; Lemberg DA; Nielsen S; Mitchell HM, 2015, 'Effect of exclusive enteral nutrition on the microbiota of children with newly diagnosed Crohn's disease', Clinical and Translational Gastroenterology, 6, http://dx.doi.org/10.1038/ctg.2014.21

Kaakoush NO; Castaño-Rodríguez N; Day AS; Lemberg DA; Leac ST; Mitchell HM, 2015, 'Faecal levels of zonula occludens toxin in paediatric patients with crohn’s disease and their association with the intestinal microbiota', Journal of Medical Microbiology, 64, pp. 303 - 306, http://dx.doi.org/10.1099/jmm.0.000005

H Alhagamhmad M; T Leach S; A Lemberg D; S Day A, 2015, 'Changing Patterns in the Epidemiology of Crohn Disease', Journal of Gastroenterology and Hepatology Research, 4, pp. 1805 - 1809, http://dx.doi.org/10.17554/j.issn.2224-3992.2015.04.550

McMullen L; T Leach S; A Lemberg D; S Day A, 2015, 'Current roles of specific bacteria in the pathogenesis of inflammatory bowel disease', AIMS Microbiology, 1, pp. 82 - 91, http://dx.doi.org/10.3934/microbiol.2015.1.82

Alhagamhmad M; Leach S; Day AS; Lemberg D, 2015, 'Mo1231 Attenuation of Intestinal Inflammation by Co-Supplementation of Glutamine and Arginine', Gastroenterology, 148, pp. S - 644, http://dx.doi.org/10.1016/s0016-5085(15)32176-4

Alhagamhmad M; Leach S; Day AS; Lemberg D, 2015, 'Mo1232 Development of an Enhanced Nutritional Therapy for the Treatment of Crohn's Disease', Gastroenterology, 148, pp. S - 644, http://dx.doi.org/10.1016/s0016-5085(15)32177-6

Ooi CY; Pang T; Leach ST; Katz T; Day AS; Jaffe A, 2015, 'Su1367 Faecal Human Beta-Defensin 2 Levels in Children With Cystic Fibrosis', Gastroenterology, 148, pp. S - 487, http://dx.doi.org/10.1016/s0016-5085(15)31638-3

Huang Y; Lemberg DA; Day AS; Dixon B; LeaC.H. S; Bujanover Y; Jaffe A; Thomas PS, 2014, 'Markers of inflammation in the breath in paediatric inflammatory bowel disease', Journal of Pediatric Gastroenterology and Nutrition, 59, pp. 505 - 510, http://dx.doi.org/10.1097/MPG.0000000000000450

Chan J; Foster R; Leach ST; Day AS; Lemberg DA, 2014, 'Tacrolimus use in pediatric inflammatory bowel disease', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 29, pp. 151 - 152, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000300&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chan J; Foster R; Lemberg DA; Leach ST; Day AS, 2014, 'Tacrolimus use in paediatric inflammatory bowel disease', JOURNAL OF CROHNS & COLITIS, 8, pp. S436 - S436, http://dx.doi.org/10.1016/S1873-9946(14)50147-X

Raheem M; Leach ST; Day AS; Lemberg DA, 2014, 'The pathophysiology of eosinophilic esophagitis', Frontiers in Pediatrics, 2, http://dx.doi.org/10.3389/fped.2014.00041

Pang T; Leach ST; Katz T; Day AS; Ooi CY, 2014, 'Fecal biomarkers of intestinal health and disease in children', Frontiers in Pediatrics, 2, pp. 1 - 12, http://dx.doi.org/10.3389/fped.2014.00006

Naidoo CMY; Leach ST; Day AS; Lemberg DA, 2014, 'Inflammatory Bowel Disease in Children of Middle Eastern Descent', INTERNATIONAL JOURNAL OF PEDIATRICS, 2014, http://dx.doi.org/10.1155/2014/906128

Leach ST; Day AS; Moore D; Lemberg DA, 2014, 'Low rate of inflammatory bowel disease in the Australian indigenous paediatric population', Journal of Paediatrics and Child Health, 50, pp. 328 - 329, http://dx.doi.org/10.1111/jpc.12535

Nahidi L; Day AS; Lemberg DA; Leach ST, 2014, 'Paediatric Inflammatory Bowel Disease: A Mechanistic Approach to Investigate Exclusive Enteral Nutrition Treatment', SCIENTIFICA, 2014, http://dx.doi.org/10.1155/2014/423817

Pang T; Leach ST; Katz T; Jaffe A; Day AS; Ooi CY, 2014, 'Elevated faecal M2-pyruvate kinase in children with cystic fibrosis: A clue to the increased risk of intestinal malignancy in adulthood?', Journal of Gastroenterology and Hepatology, pp. n/a - n/a, http://dx.doi.org/10.1111/jgh.12842

Dhaliwal J; Leach S; Katz T; Nahidi L; Pang T; Lee JM; Strachan R; Day AS; Jaffe A; Ooi CY, 2014, 'Intestinal Inflammation and Impact on Growth in Children With Cystic Fibrosis', Journal of Pediatric Gastroenterology and Nutrition, pp. 1 - 1, http://dx.doi.org/10.1097/MPG.0000000000000683

Pang T; Leach ST; Day AS; Jaffe A; Ooi CY, 2014, 'Tu1240 Faecal M2-Pyruvate Kinase in Children With Cystic Fibrosis: Does Increased Cell Turnover From Childhood Explain the Increased Risk of Gastrointestinal Malignancy in Adulthood?', Gastroenterology, 146, pp. S - 792, http://dx.doi.org/10.1016/s0016-5085(14)62860-2

Kaakoush NO; Castaño-Rodríguez N; Day AS; Lemberg DA; Leach ST; Mitchell HM, 2013, 'Campylobacter concisus and exotoxin 9 levels in paediatric patients with Crohn's disease and their association with the intestinal microbiota', Journal of Medical Microbiology, 63, pp. 99 - 105, http://dx.doi.org/10.1099/jmm.0.067231-0

Nahidi L; Leach ST; Lemberg DA; Day AS, 2013, 'Osteoprotegerin exerts its pro-inflammatory effects through nuclear factor-κb activation', Digestive Diseases and Sciences, 58, pp. 3144 - 3155, http://dx.doi.org/10.1007/s10620-013-2851-2

Nahidi L; Leach ST; Mitchell HM; Kaakoush NO; Lemberg DA; Munday JS; Huinao K; Day AS, 2013, 'The effect of nutritional and non-nutritional therapies on gut barrier function and mucosal healing in a colitis mouse model', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 28, pp. 16 - 16, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000324106900032&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Nahidi L; Leach ST; Mitchell HM; Kaakoush NO; Lemberg DA; Munday JS; Huinao K; Day AS, 2013, 'Inflammatory bowel disease therapies and gut function in a colitis mouse model', BioMed Research International, 2013, http://dx.doi.org/10.1155/2013/909613

Day AS; Ehn M; Gearry RB; Lemberg DA; Leach ST, 2013, 'Fecal S100A12 in healthy infants and children', Disease Markers, 35, pp. 295 - 299, http://dx.doi.org/10.1155/2013/873582

Alhagamhmad MH; Lemberg DA; Day AS; Leach ST, 2013, 'Defining the therapeutic and preventative anti-inflammatory benefits of curcumin in vitro', OA Inflammation, 1, http://dx.doi.org/10.13172/2052-787x-1-2-1019

Hallab JC; Leach ST; Zhang L; Mitchell HM; Oei J; Lui K; Day AS; Hallab J, 2013, 'Molecular characterization of bacterial colonization in the preterm and term infant's intestine', Indian Journal of Pediatrics, 80, pp. 1 - 5, http://dx.doi.org/10.1007/s12098-012-0753-5

Naing Z; Rayner BS; Killikulangara ; Vunnam K; Leach ST; Mciver CJ; Scott GMS; Craig ME; Lui K; Rawlinson WD, 2013, 'Prevalence of viruses in stool of premature neonates at a neonatal intensive care unit', Journal of Paediatrics and Child Health, 49, pp. E221 - E226, http://dx.doi.org/10.1111/jpc.12113

Nahidi L; Leach ST; Mitchell HM; Kaakoush NO; Lemberg DA; Munday J; Huinao K; Day AS, 2013, 'Su2016 Nutritional Therapy Modulates Inflammation and Improves Altered Barrier Function in a Mouse Model of Colitis', Gastroenterology, 144, pp. S - 532, http://dx.doi.org/10.1016/s0016-5085(13)61978-2

Lambert B; Lemberg DA; Leach ST; Day AS, 2012, 'Long-Term Efficacy of Enteral Nutrition for Patients with Crohn's Disease Reply', DIGESTIVE DISEASES AND SCIENCES, 57, pp. 3311 - 3311, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000311513900044&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lambert B; Lemberg DA; Leach ST; Day AS, 2012, 'Reply', Digestive Diseases and Sciences, 57, pp. 3311, http://dx.doi.org/10.1007/s10620-012-2444-5

Alhagamhmad MH; Day AS; Lemberg DA; Leach ST, 2012, 'An update of the role of nutritional therapy in the management of Crohn’s disease', Journal of Gastroenterology, 47, pp. 872 - 882, http://dx.doi.org/10.1007/s00535-012-0617-9

Back to profile page